3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
17
Peritoneal Neoplasms
13
Fallopian Tube Neoplasms
10
Colorectal Neoplasms
8
Stomach Neoplasms
5
Carcinoma, Ovarian Epithelial
5
Hyperthermia
3
Gastrointestinal Neoplasms
3
Appendiceal Neoplasms
3
Adrenocortical Carcinoma
3
Sarcoma
2
Rhabdomyosarcoma
2
Neoplasms
2
Mesothelioma, Malignant
2
Mesothelioma
2
Glioma
2
Glioblastoma
2
Desmoplastic Small Round Cell Tumor
2
Colonic Neoplasms
2
Carcinoma
2
Brain Neoplasms
2
Adenoma, Islet Cell
2
Wilms Tumor
1
Retroperitoneal Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Pseudomyxoma Peritonei
1
Pleural Effusion, Malignant
1
Peritoneal Cavity Cancer
1
Pelvic Neoplasms
1
Interventions
pembrolizumab
156
Gemcitabine
139
Capecitabine
121
Paclitaxel
119
Fluorouracil
116
Oxaliplatin
110
Bevacizumab
104
Nivolumab
97
Leucovorin
97
Docetaxel
93
Cisplatin
90
Irinotecan
88
Carboplatin
85
Radiosurgery
83
Cyclophosphamide
71
Cetuximab
70
Magnetic Resonance Spectroscopy
68
Trastuzumab
56
Specimen Handling
56
Biopsy
56
Radiotherapy
55
Ipilimumab
52
Everolimus
48
Pemetrexed
46
Drug Therapy
45
Albumin-Bound Paclitaxel
44
130-nm albumin-bound paclitaxel
43
Doxorubicin
41
Fulvestrant
38
aldesleukin
37
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neoplasm Metastasis
×
Cytoreduction Surgical Procedures
×
Clear all
NCT00454519
2009-02-13
IPHC
Wuhan University
Phase 2
Unknown
60 enrolled